Melanoma
Community Translations
Trametinib plus dabrafenib for unresectable or metastatic melanoma with BRAF V600E or V600K mutations
Case-Based Review
Cutaneous Melanoma
Conference Coverage
VIDEO: Drug combo delivers ‘unprecedented’ metastatic melanoma survival
Conference Coverage
VIDEO: Advanced melanoma on brink of immunotherapy ‘revolution’
Conference Coverage
VIDEO: Pembrolizumab may herald new hope in advanced melanoma
Conference Coverage
‘Unprecedented’ overall survival of metastatic melanoma
Key clinical point: A combination of immune checkpoint inhibitors may prove to be a successful approach in the treatment of patients with...
News
High rate of durable responses to pembrolizumab in metastatic melanoma
Major finding: In a phase I study of pembrolizumab in patients with advanced melanoma, 1-year overall survival was 69%, and 88% of patients who...
News
ASCO 2014: Dr. Jeffrey A. Sosman gives his top picks in melanoma research
News
Consumer Reports: Sunscreen SPF claims largely inaccurate
Commentary
Drugs approved in 2013
News
Nonmelanoma skin cancer linked to increased fracture risk in postmenopausal women
Key clinical point: A history of nonmelanoma skin cancer may predispose patients to bone fractures.Major finding: Incident lower arm fracture was...